Table 1 Maternal, gestational, and newborn characteristics
From: Primum non nocere: earlier cessation of glucose monitoring is possible
Overall | Glucose < 2.2 mM ‘hypoglycaemia’ | Glucose < 1.5 mM ‘severe hypoglycaemia’ | |
|---|---|---|---|
Total number of newborns | 1570 | 762/1570 (48.5%) | 271/1570 (17.2%) |
Gestational age, weeks* | 38.29 (36.43–39.86) | 37.86 (36.29–39.43) | 37.49 (36.14–38.86) |
Birth weight, g** | 3106 ± 814 | 3043 ± 819 | 2980 ± 783 |
Sex | |||
Male | 804/1570 (51.2%) | 395/804 (49.1%) | 133/804 (16.5%) |
Females | 766/1570 (48.8%) | 367/766 (47.9%) | 138/766 (18.0%) |
Single/multiple birth | |||
Singleton | 1385/1570 (88%) | 657/1385 (47.4%) | 238/1385 (17.2%) |
Twin | 164/1570 (10.4%) | 72/165 (43.9%) | 27/165 (16.4%) |
Triplet | 20/1570 (1.3%) | 8/20 (40.0%) | 6/20 (30.0%) |
Preterm delivery | |||
Total preterm deliveries | 526/1570 (33.5%) | 298/526 (56.7%) | 115/526 (21.9%) |
34–35 weeks | 102/526 (19.4%) | 51/102 (50.0%) | 22/102 (21.6%) |
35–36 weeks | 163/526 (31.0%) | 85/163 (52.1%) | 36/163 (22.1%) |
36–37 weeks | 261/526 (49.6%) | 162/261 (62.1%) | 57/261 (21.8%) |
Weight | |||
LGA (p > 90) | 433/1570 (27.6%) | 198/433 (45.7%) | 61/433 (14.1%) |
Extremely LGA (p > 97.7) | 114/1570 (7.4%) | 52/114 (45.6%) | 17/114 (14.9%) |
SGA (p < 10) | 508/1570 (32.4%) | 233/508 (45.9%) | 115/508 (22.6%) |
Extremely SGA (p < 2.3) | 131/1570 (8.3%) | 69/131 (52.7%) | 22/131 (16.8%) |
Diabetes | |||
Total | 300/1570 (19.1%) | 154/300 (51.3%) | 66/300 (22.0%) |
T1DM/ T2DM | 41/300 (13.7%) | 33/41 (80.5%) | 18/41 (43.9%) |
GDM | 259/300 (86.3%) | 121/259 (46.7%) | 48/259 (18.5%) |